Execus (EXEC) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
13 Oct, 2026Executive summary
H1 2025 revenue rose 94.3% YoY to €3.973m and production value increased 104% to €4.393m; growth included ZCA Digital, acquired in January, and organic gains across existing businesses.
On a homogeneous perimeter, revenue increased 24.3% to €3.973m and EBITDA rose 18.2% to €483k; EBITDA margin was 11.0% versus 11.9% in H1 2024.
Consolidated net loss narrowed to €48k from €221k; net cash was €691k at June-end, down from €1.309m at FY24-end.
Growth strategy combines direct-sales expansion, AI-led product development and targeted acquisitions; Vanilla Marketing and ZCA Digital were acquired during the half, with integration underway.
Financial highlights
Sales revenue €3.973m, up 94.3% YoY; production value €4.393m, up 104%.
EBITDA €483k, up 458% reported and 18.2% on a homogeneous-perimeter basis; EBITDA margin 11.0%, versus 4.0% reported and 11.9% homogeneous in H1 2024.
EBIT €44k versus a €192k loss; net loss €48k versus €221k, including €80k loss attributable to the parent and €32k profit attributable to non-controlling interests.
Organic-perimeter revenue grew 24.3%; €1.360m of reported revenue growth came from ZCA and €569k from organic growth at the other businesses.
Operating cash flow was negative €786k, investing cash flow negative €1.293m and financing cash flow positive €1.925m; period-end cash was €1.383m.
Outlook and guidance
FY25 priorities include integrating ZCA and Vanilla, capturing operational and commercial synergies, and continuing to assess complementary acquisition targets.
AI platforms including Execus BI and Digital Echo are being developed, alongside an AI-agent network; commercial launch of virtual agents was planned for October 2025.
Direct sales remains a core growth driver; the sales network had 29 agents/agencies and 4 lead generators at June-end, with further reinforcement planned.
2026 prospects were described as positive, supported by modular and recurring-revenue offerings and increased specialization in AI solutions; investments and costs are expected to remain higher in the short term.
A €500k medium-/long-term loan received in July 2025 is intended to fund internal development and accelerate organic growth.
Latest events from Execus
- €1.215m H1 sales, 39.8% EBITDA margin and €1.415m net cash; IPO raised ~€930k.EXEC
H1 2023 - Direct sales gained share as 2023 revenue and EBITDA declined; integration and growth are the 2024 focus.EXEC
H2 2023 - Acquisitions lifted reported sales, while channel weakness and investment drove losses.EXEC
H1 2024 - Acquisition-led sales growth masked weaker pro forma revenue and sharply lower EBITDA.EXEC
H2 2024